STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Nautilus Biotechnology (NASDAQ: NAUT), a pioneer in single-molecule protein analysis platforms, has scheduled its Q2 2025 financial results announcement for July 31, 2025, before market open.

The company will host a conference call and webcast at 5:30 AM PT / 8:30 AM ET to discuss quarterly results, business developments, and future outlook. Investors can access the live webcast through the company's website at www.nautilus.bio.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-8.59% News Effect

On the day this news was published, NAUT declined 8.59%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the second quarter 2025 before market open on Thursday, July 31, 2025.

The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.nautilus.bio.

About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.

Media Contact
press@nautilus.bio 

Investor Contact
investorrelations@nautilus.bio 


FAQ

When will Nautilus Biotechnology (NAUT) release Q2 2025 earnings?

Nautilus Biotechnology will release Q2 2025 earnings on Thursday, July 31, 2025, before the market opens.

What time is the Nautilus Biotechnology (NAUT) Q2 2025 earnings call?

The earnings conference call is scheduled for 5:30 AM Pacific Time / 8:30 AM Eastern Time on July 31, 2025.

How can I listen to Nautilus Biotechnology's Q2 2025 earnings call?

Investors can access the live webcast through the Investors section of Nautilus Biotechnology's website at www.nautilus.bio.

What does Nautilus Biotechnology (NAUT) do?

Nautilus Biotechnology is a company that pioneers single-molecule protein analysis platform technology for quantifying the proteome.
Nautilus Biotechnology Inc

NASDAQ:NAUT

NAUT Rankings

NAUT Latest News

NAUT Latest SEC Filings

NAUT Stock Data

250.08M
71.18M
33.5%
46.34%
0.18%
Biotechnology
Laboratory Analytical Instruments
Link
United States
SEATTLE